SCHEMBL8525906

SCHEMBL8525906

CC(C)c1nnc(-c2ccccn2)[nH]c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 5/20 0.50
SMN1; SMN2 Q16637 5/20 0.50
L3MBTL1 Q9Y468 4/20 0.50
LMNA P02545 4/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 2/20 0.50
POLB P06746 1/20 0.50
ALDH1A1 P00352 4/20 0.49
NPC1 O15118 4/20 0.49
RAB9A P51151 4/20 0.49
GAA P10253 1/20 0.49
HIF1A Q16665 1/20 0.49
BTK Q06187 1/20 0.47
KRAS P01116 2/20 0.45
HSP90AA1 P07900 1/20 0.44
KMT2A Q03164 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAPT P10636 2/20 0.43
AGTR1 P30556 1/20 0.43
ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8525373 0.86 HTT (0.46) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL5730778 0.82 HTT (0.45) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL5916410 0.82 ALDH1A1 (0.44) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL11655439 0.80 L3MBTL1 (0.60) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL8525541 0.78 SMN1; SMN2 (0.47) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL12410792 0.78 BTK (0.45) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL5730718 0.76 ALDH1A1 (0.42) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL5478697 0.76 KDM4E (0.59) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL11655297 0.76 HTT (0.50) HTTSMN1; SMN2L3MBTL1LMNATDP1
SCHEMBL8524777 0.74 NPC1 (0.68) HTTSMN1; SMN2L3MBTL1LMNATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999007352-A2 METHOD FOR PROMOTING EXPRESSION OF LDL RECEPTOR GENE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-02-18 WO claimed
WO-1999007352-A2 METHOD FOR PROMOTING EXPRESSION OF LDL RECEPTOR GENE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1999-02-18 WO disclosed